Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Non-steroidal Anti-inflammatory Drugs (NSAID) Market to 2027 - Global Analysis and Forecasts by Dosage Form (Oral, Topical, Injectable); Indication (Postoperative Pain, Bone and Joint Pain, Sports Injuries, Menstruation, Others); End User (Hospital Pharmacies, Retail Pharmacies, Others), and Geography

Report Code: TIPRE00004421 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
The non-steroidal anti-inflammatory drugs are a type of pain reliever that help to reduce inflammation and lower fevers. The NSAIDs are the most prescribed medications, which are used to treat conditions that cause pain or inflammation, such as arthritis. The non-steroidal anti-inflammatory drugs such as, aspirin and ibuprofen, are considered as the first line of treatment in pain management due to three basic properties: analgesic, antipyretic, and anti-inflammatory.

MARKET DYNAMICS
The non-steroidal anti-inflammatory drugs (NSAID) market is anticipated to grow due to rising prevalence of bone & joint disorders such as rheumatoid arthritis & osteoarthritis, and rising incidence of pain disorders and increase in geriatric population with high risk of various diseases across the globe. However, increase in number of hospital surgeries and growing adoption of pain management therapeutics are likely to grow the market during the forecast period.

MARKET SCOPE
The "Global Non-Steroidal Anti-Inflammatory Drugs (NSAID) Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of non-steroidal anti-inflammatory drugs (NSAID) market with detailed market segmentation by dosage form, indication, end user and geography. The global non-steroidal anti-inflammatory drugs (NSAID) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading non-steroidal anti-inflammatory drugs (NSAID) market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global non-steroidal anti-inflammatory drugs (NSAID) market is segmented on the basis of dosage form, indication, and end user. On the basis of dosage form, oral, topical and injectable. Based on indication, the market is classified as, postoperative pain, bone & joint pain, sports injuries, menstruation and others. The non-steroidal anti-inflammatory drugs (NSAID) market, on the basis of end user is categorized as, hospital pharmacies, retail pharmacies and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global non-steroidal anti-inflammatory drugs (NSAID) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The non-steroidal anti-inflammatory drugs (NSAID) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting non-steroidal anti-inflammatory drugs (NSAID) market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the non-steroidal anti-inflammatory drugs (NSAID) market in these regions.

MARKET PLAYERS
The reports cover key developments in the non-steroidal anti-inflammatory drugs (NSAID) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from non-steroidal anti-inflammatory drugs (NSAID) market are anticipated to lucrative growth opportunities in the future with the rising demand for non-steroidal anti-inflammatory drugs (NSAID) market in the global market. Below mentioned is the list of few companies engaged in the non-steroidal anti-inflammatory drugs (NSAID) market.

The report also includes the profiles of key non-steroidal anti-inflammatory drugs (NSAID) market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Pfizer Inc.
  • Reckitt Benckiser Group plc.
  • Novartis AG
  • Bayer AG
  • DAIICHI SANKYO COMPANY, LIMITED.
  • AbbVie Inc.
  • GlaxoSmithKline plc.
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AstraZeneca
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market - By Dosage Form
1.3.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market - By Indication
1.3.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market - By End User
1.3.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) MARKET - GLOBAL MARKET ANALYSIS
6.1. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) - GLOBAL MARKET OVERVIEW
6.2. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE FORM
7.1. OVERVIEW
7.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
7.3. ORAL
7.3.1. Overview
7.3.2. Oral Market Forecast and Analysis
7.4. TOPICAL
7.4.1. Overview
7.4.2. Topical Market Forecast and Analysis
7.5. INJECTABLE
7.5.1. Overview
7.5.2. Injectable Market Forecast and Analysis
8. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. POSTOPERATIVE PAIN
8.3.1. Overview
8.3.2. Postoperative Pain Market Forecast and Analysis
8.4. BONE AND JOINT PAIN
8.4.1. Overview
8.4.2. Bone and Joint Pain Market Forecast and Analysis
8.5. SPORTS INJURIES
8.5.1. Overview
8.5.2. Sports Injuries Market Forecast and Analysis
8.6. MENSTRUATION
8.6.1. Overview
8.6.2. Menstruation Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
10.1.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis
10.1.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Dosage Form
10.1.4 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Indication
10.1.5 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By End User
10.1.6 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Countries
10.1.6.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.1.6.1.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.1.6.1.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.1.6.1.3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.1.6.2 Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.1.6.2.1 Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.1.6.2.2 Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.1.6.2.3 Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.1.6.3 Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.1.6.3.1 Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.1.6.3.2 Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.1.6.3.3 Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.2. EUROPE
10.2.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
10.2.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis
10.2.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Dosage Form
10.2.4 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Indication
10.2.5 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By End User
10.2.6 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.2.6.1.1 Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.2.6.1.2 Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.2.6.1.3 Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.2.6.2 France Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.2.6.2.1 France Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.2.6.2.2 France Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.2.6.2.3 France Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.2.6.3 Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.2.6.3.1 Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.2.6.3.2 Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.2.6.3.3 Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.2.6.4 Spain Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.2.6.4.1 Spain Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.2.6.4.2 Spain Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.2.6.4.3 Spain Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.2.6.5 United Kingdom Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.2.6.5.1 United Kingdom Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.2.6.5.2 United Kingdom Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.2.6.5.3 United Kingdom Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
10.3.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis
10.3.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Dosage Form
10.3.4 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.3.6.1.1 Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.3.6.1.2 Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.3.6.1.3 Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.3.6.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.3.6.2.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.3.6.2.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.3.6.2.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.3.6.3 India Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.3.6.3.1 India Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.3.6.3.2 India Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.3.6.3.3 India Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.3.6.4 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.3.6.4.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.3.6.4.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.3.6.4.3 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.3.6.5 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.3.6.5.1 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.3.6.5.2 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.3.6.5.3 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
10.4.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis
10.4.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Dosage Form
10.4.4 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.4.6.1.1 South Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.4.6.1.2 South Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.4.6.1.3 South Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.4.6.2 Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.4.6.2.1 Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.4.6.2.2 Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.4.6.2.3 Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.4.6.3 U.A.E Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.4.6.3.1 U.A.E Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.4.6.3.2 U.A.E Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.4.6.3.3 U.A.E Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
10.5.2 South and Central America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis
10.5.3 South and Central America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Dosage Form
10.5.4 South and Central America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By End User
10.5.6 South and Central America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.5.6.1.1 Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.5.6.1.2 Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.5.6.1.3 Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
10.5.6.2 Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Market
10.5.6.2.1 Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Dosage Form
10.5.6.2.2 Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Indication
10.5.6.2.3 Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) MARKET, KEY COMPANY PROFILES
12.1. PFIZER INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. RECKITT BENCKISER GROUP PLC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BAYER AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. DAIICHI SANKYO COMPANY, LIMITED.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ABBVIE INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MERCK AND CO., INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ELI LILLY AND COMPANY
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ASTRAZENECA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc.
2. Reckitt Benckiser Group plc.
3. Novartis AG
4. Bayer AG
5. DAIICHI SANKYO COMPANY, LIMITED.
6. AbbVie Inc.
7. GlaxoSmithKline plc.
8. Merck & Co. , Inc.
9. Eli Lilly and Company
10. AstraZeneca
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book